查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1602102

全球智慧注射器市场：按治疗方法、应用和最终用户分类 - 预测 2025-2030

Smart Syringes Market by Theraupetics (Active Safety Syringes, Auto-disable Syringes, Passive Safety Syringes), Application (Blood Specimen Collection, Drug Delivery, Vaccination), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年智慧注射器市值为84.4亿美元，预计2024年将达到104.6亿美元，复合年增长率为24.61%，到2030年将达到393.8亿美元。

智慧注射器是一种创新的医疗设备，旨在提高医疗环境的安全性和效率。与传统注射器不同，智慧注射器配备自动停用、被动或主动安全机制等功能，旨在防止重复使用和针刺事故，并防止污染、爱滋病毒和肝炎等感染疾病的传播。对智慧注射器的需求源于全球卫生政策提倡注射安全，以减少对医护人员的Sharp Corporation伤害，从而导致整个医疗机构的需求增加。智慧注射器主要用于医院、诊所和门诊手术中心，最终用途扩展到免疫计划、治疗注射和药物传输系统等。智慧注射器市场的关键成长要素是对注射製剂的日益重视、需要重复安全给药的慢性疾病数量的增加以及推动安全工程设备使用的严格要求。潜在的机会包括智慧技术的进步，例如支援物联网的注射器，以提高对治疗通讯协定的遵守率和用于有效库存管理的 GPS 整合解决方案，以及增加医疗基础设施投资的开拓中市场。然而，与传统注射器相比成本较高、低收入地区认知度较低以及传统医疗实践变化带来的阻力等挑战可能会阻碍市场成长。创新技术包括具有成本效益的生产解决方案、智慧给药和电子健康记录整合以改善跟踪，以及开发环保材料以提高永续性。目前市场呈现出一个动态环境，其特点是技术快速进步、监管环境不断变化以及医疗安全意识不断增强，这使得想要保持竞争优势并影响未来发展变得困难，对于想要回报的市场参与者来说，时机已经成熟。

主要市场统计
基准年[2023] 84.4亿美元
预测年份 [2024] 104.6亿美元
预测年份 [2030] 393.8亿美元
复合年增长率（%） 24.61%

市场动态：揭示快速发展的智慧注射器市场的关键市场洞察

供需的动态交互作用正在改变智慧注射器市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 各种目标疾病盛行率上升和老年人口增加
    • 增加疫苗宣传活动和倡议
    • 医疗相关感染和针刺伤的发生率增加
  • 市场限制因素
    • 智慧注射器产品召回
  • 市场机会
    • 对环境安全和自毁注射器的需求不断增长
    • 对病人健康和安全的严格规定
  • 市场挑战
    • 新兴国家对智慧注射器的认知度和使用率较低

波特五力：驾驭智慧注射器市场的策略工具

波特的五力框架是了解智慧注射器市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解智慧注射器市场的外部影响

外部宏观环境因素在塑造智慧注射器市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解智慧注射器市场竞争状况

对智慧注射器市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵智慧注射器市场厂商绩效评估

FPNV定位矩阵是评估智慧注射器市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 各种目标疾病的盛行率上升以及老年人口的增加
      • 加大疫苗宣传活动和力度
      • 医疗机构感染案例增多，针刺事故增多
    • 抑制因素
      • 智慧注射器产品召回
    • 机会
      • 对环境安全且具有自动停用功能的注射器的需求不断增长
      • 关于病人健康和安全的严格规定
    • 任务
      • 新兴国家对智慧注射器的认知度和使用率较低
  • 市场区隔分析
    • 治疗：在疫苗宣传活动中增加使用自毁式註射器
    • 应用：智慧注射器在给药方面的广泛适用性
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 智慧注射器市场：依治疗方法

  • 主动安全注射器
  • 自动禁用注射器
  • 被动安全注射器

第七章智慧注射器市场：依应用分类

  • 血液检体采集
  • 药物输送
  • 疫苗接种

第八章智慧注射器市场：依最终用户分类

  • 诊断中心
  • 医院和 HMO
  • 医生诊所

第九章 北美、南美智慧注射器市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太智慧注射器市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东、非洲智慧注射器市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Terumo Corporation India 为需要每日註射胰岛素的患者推出胰岛素注射器
    • Sharp Corporation Technology 与 Nephron Pharmaceuticals 签订资产购买协议，收购 Inject EZ 特种共聚物注射器製造厂，并签订价值超过 4 亿美元的 10 年期购买协议
    • Stevanato Group 与 Transcoject 合作，为製药业提供预填充式注射器聚合物选择

公司名单

  • Shanghai Kohope Medical Co., Ltd.
  • Hindustan Syringes & Medical Devices Ltd.
  • MHC Medical Products, LLC
  • Shimadzu Corporation
  • Biocorp by Novo Nordisk A/S
  • Sharps Technology, Inc.
  • Stevanato Group
  • Cardinal Health, Inc.
  • Owen Mumford Limited
  • Tecan Group Ltd.
  • B. Braun SE
  • Vogt Medical Vertrieb GmbH
  • Sol-Millennium Medical Group
  • AdvaCare Pharma
  • Agilent Technologies, Inc.
  • Baxter International Inc.
  • Gerresheimer AG
  • Numedico Technologies Pty Ltd.
  • Thermo Fisher Scientific Inc.
  • UltiMed, Inc.
  • Terumo Corporation
  • Revolutions Medical Corporation
  • Medtronic PLC
  • Retractable Technologies, Inc.
  • Parker-Hannifin Corporation
  • Becton, Dickinson and Company
  • DMC Medical Limited
  • Smiths Group PLC
Product Code: MRR-03050D1B2D40

The Smart Syringes Market was valued at USD 8.44 billion in 2023, expected to reach USD 10.46 billion in 2024, and is projected to grow at a CAGR of 24.61%, to USD 39.38 billion by 2030.

Smart syringes are innovative medical devices engineered to enhance safety and efficiency in medical practices. Unlike traditional syringes, smart syringes are equipped with features such as auto-disable, passive or active safety mechanisms designed to prevent re-use and needle stick injuries, addressing critical healthcare concerns such as contamination and the spread of infections like HIV and Hepatitis. The necessity for smart syringes arises from global health policies advocating for safety in injection practices to reduce sharps injuries among healthcare workers, subsequently driving their demand across healthcare settings. They are predominantly utilized in hospitals, clinics, and ambulatory surgical centers, with end-use extending particularly to immunization programs, therapeutic injections, and drug delivery systems. A major growth factor in the smart syringe market is the rising emphasis on injectable formulations, increasing incidences of chronic diseases necessitating repeated and safe medication delivery, coupled with stringent government regulations promoting the use of safety-engineered devices. Potential opportunities include advancements in smart technologies such as IoT-enabled syringes enhancing adherence to treatment protocols and GPS-integrated solutions for effective inventory management, alongside expanding markets in developing regions with growing healthcare infrastructure investments. However, challenges such as high costs compared to traditional syringes, limited awareness in low-income regions, and resistance due to changes in traditional medical practices may hinder market growth. Innovations could focus on cost-effective production solutions, integrating smart drug delivery with electronic health records for better tracking, and eco-friendly material development to enhance sustainability. The market currently exhibits a dynamic environment characterized by rapid technological advancements, shifting regulatory landscapes, and an increasing awareness of healthcare safety, making it ripe for strategic investments in R&D and partnerships with tech companies for market players aiming to maintain competitive advantage and influence future developments.

KEY MARKET STATISTICS
Base Year [2023] USD 8.44 billion
Estimated Year [2024] USD 10.46 billion
Forecast Year [2030] USD 39.38 billion
CAGR (%) 24.61%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Smart Syringes Market

The Smart Syringes Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising Prevalence of Various Target Diseases and Growth of the Geriatic Population
    • Increasing Number of Vaccination Campaigns and Initiatives
    • Major incidents of Healthcare-Acquired Infections and Rise in Count of Needle Stick Injuries
  • Market Restraints
    • Smart Syringes Product Recalls
  • Market Opportunities
    • Growing Need for Environmentally Safe and Auto Disable Syringes
    • Stringent Regulation for Patient Health and Safety
  • Market Challenges
    • Low Awareness and Usage of Smart Syringes in Developing Countries

Porter's Five Forces: A Strategic Tool for Navigating the Smart Syringes Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Smart Syringes Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Smart Syringes Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Smart Syringes Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Smart Syringes Market

A detailed market share analysis in the Smart Syringes Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Smart Syringes Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Smart Syringes Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Smart Syringes Market, highlighting leading vendors and their innovative profiles. These include Shanghai Kohope Medical Co., Ltd., Hindustan Syringes & Medical Devices Ltd., MHC Medical Products, LLC, Shimadzu Corporation, Biocorp by Novo Nordisk A/S, Sharps Technology, Inc., Stevanato Group, Cardinal Health, Inc., Owen Mumford Limited, Tecan Group Ltd., B. Braun SE, Vogt Medical Vertrieb GmbH, Sol-Millennium Medical Group, AdvaCare Pharma, Agilent Technologies, Inc., Baxter International Inc., Gerresheimer AG, Numedico Technologies Pty Ltd., Thermo Fisher Scientific Inc., UltiMed, Inc., Terumo Corporation, Revolutions Medical Corporation, Medtronic PLC, Retractable Technologies, Inc., Parker-Hannifin Corporation, Becton, Dickinson and Company, DMC Medical Limited, and Smiths Group PLC.

Market Segmentation & Coverage

This research report categorizes the Smart Syringes Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Theraupetics, market is studied across Active Safety Syringes, Auto-disable Syringes, and Passive Safety Syringes.
  • Based on Application, market is studied across Blood Specimen Collection, Drug Delivery, and Vaccination.
  • Based on End User, market is studied across Diagnostics Center, Hospitals & HMOs, and Physician Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Prevalence of Various Target Diseases and Growth of the Geriatic Population
      • 5.1.1.2. Increasing Number of Vaccination Campaigns and Initiatives
      • 5.1.1.3. Major incidents of Healthcare-Acquired Infections and Rise in Count of Needle Stick Injuries
    • 5.1.2. Restraints
      • 5.1.2.1. Smart Syringes Product Recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing Need for Environmentally Safe and Auto Disable Syringes
      • 5.1.3.2. Stringent Regulation for Patient Health and Safety
    • 5.1.4. Challenges
      • 5.1.4.1. Low Awareness and Usage of Smart Syringes in Developing Countries
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Therapeutics: Increasing use of auto-disable syringes for immunization campaigns
    • 5.2.2. Application: Wide applicability of smart syringes for drug delivery
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Smart Syringes Market, by Theraupetics

  • 6.1. Introduction
  • 6.2. Active Safety Syringes
  • 6.3. Auto-disable Syringes
  • 6.4. Passive Safety Syringes

7. Smart Syringes Market, by Application

  • 7.1. Introduction
  • 7.2. Blood Specimen Collection
  • 7.3. Drug Delivery
  • 7.4. Vaccination

8. Smart Syringes Market, by End User

  • 8.1. Introduction
  • 8.2. Diagnostics Center
  • 8.3. Hospitals & HMOs
  • 8.4. Physician Clinics

9. Americas Smart Syringes Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Smart Syringes Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Smart Syringes Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Terumo India Introduces Insulin Syringe for Patients Requiring Daily Insulin Injections
    • 12.3.2. Sharps Technology Signs Asset Purchase Agreement to Acquire InjectEZ Specialty Copolymer Syringe Manufacturing Facility and a 10-Year Purchase Agreement for Over USD 400 Million from Nephron Pharmaceuticals
    • 12.3.3. Stevanato Group Collaborates with Transcoject to Provide Pre-Fillable Syringe Polymer Options for Pharma

Companies Mentioned

  • 1. Shanghai Kohope Medical Co., Ltd.
  • 2. Hindustan Syringes & Medical Devices Ltd.
  • 3. MHC Medical Products, LLC
  • 4. Shimadzu Corporation
  • 5. Biocorp by Novo Nordisk A/S
  • 6. Sharps Technology, Inc.
  • 7. Stevanato Group
  • 8. Cardinal Health, Inc.
  • 9. Owen Mumford Limited
  • 10. Tecan Group Ltd.
  • 11. B. Braun SE
  • 12. Vogt Medical Vertrieb GmbH
  • 13. Sol-Millennium Medical Group
  • 14. AdvaCare Pharma
  • 15. Agilent Technologies, Inc.
  • 16. Baxter International Inc.
  • 17. Gerresheimer AG
  • 18. Numedico Technologies Pty Ltd.
  • 19. Thermo Fisher Scientific Inc.
  • 20. UltiMed, Inc.
  • 21. Terumo Corporation
  • 22. Revolutions Medical Corporation
  • 23. Medtronic PLC
  • 24. Retractable Technologies, Inc.
  • 25. Parker-Hannifin Corporation
  • 26. Becton, Dickinson and Company
  • 27. DMC Medical Limited
  • 28. Smiths Group PLC

LIST OF FIGURES

  • FIGURE 1. SMART SYRINGES MARKET RESEARCH PROCESS
  • FIGURE 2. SMART SYRINGES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SMART SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SMART SYRINGES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL SMART SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL SMART SYRINGES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL SMART SYRINGES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL SMART SYRINGES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES SMART SYRINGES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES SMART SYRINGES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SMART SYRINGES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. SMART SYRINGES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. SMART SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SMART SYRINGES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SMART SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SMART SYRINGES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL SMART SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. SMART SYRINGES MARKET DYNAMICS
  • TABLE 7. GLOBAL SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL SMART SYRINGES MARKET SIZE, BY ACTIVE SAFETY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL SMART SYRINGES MARKET SIZE, BY AUTO-DISABLE SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL SMART SYRINGES MARKET SIZE, BY PASSIVE SAFETY SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL SMART SYRINGES MARKET SIZE, BY BLOOD SPECIMEN COLLECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL SMART SYRINGES MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL SMART SYRINGES MARKET SIZE, BY VACCINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL SMART SYRINGES MARKET SIZE, BY DIAGNOSTICS CENTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL SMART SYRINGES MARKET SIZE, BY HOSPITALS & HMOS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL SMART SYRINGES MARKET SIZE, BY PHYSICIAN CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS SMART SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES SMART SYRINGES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC SMART SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA SMART SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM SMART SYRINGES MARKET SIZE, BY THERAUPETICS, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM SMART SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM SMART SYRINGES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. SMART SYRINGES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. SMART SYRINGES MARKET, FPNV POSITIONING MATRIX, 2023